Sign inGet started

Kuwahara Jon

Insider CIK 1664784 · NVUS See Remarks · NONE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NVUS Novus Therapeutics, Inc. A Award deriv2020-09-112020-09-152,145— $02,145SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2020-03-192020-03-2050,000— $050,000SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2019-09-262019-09-3060,000— $060,000SEC↗
NVUS Novus Therapeutics, Inc. S Sale2019-05-212019-05-221,058$1.91 $2.0K5,974SEC↗
NVUS Novus Therapeutics, Inc. S Sale2019-05-202019-05-224,218$1.96 $8.3K7,032SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2019-03-142019-03-1825,000— $025,000SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2018-03-132018-03-1512,000— $012,000SEC↗
NVUS Novus Therapeutics, Inc. A Award2018-03-132018-03-1511,250— $011,250SEC↗
NONE EMMAUS LIFE SCIENCES, INC. A Award deriv2018-02-272018-03-0510,000— $010,000SEC↗
NVUS Novus Therapeutics, Inc. A Award deriv2017-07-102017-07-1035,000— $035,000SEC↗
EMMA EMMAUS LIFE SCIENCES, INC. A Award deriv2016-05-102016-05-12100,000— $0100,000SEC↗
NONE EMMAUS LIFE SCIENCES, INC. A Award deriv2016-01-142016-06-03100,000— $0100,000SEC↗
NONE EMMAUS LIFE SCIENCES, INC. A Award deriv2016-01-142016-01-25100,000— $0100,000SEC↗